A digital therapeutic for proactive monitoring of patients on immune checkpoint inhibitor therapy for early detection of immune-related adverse events

被引：0
|
作者：
Singhal, Shyamali Mallick
Dormady, Shane
Li, Jiali
Singhal, Shiva
Chin, Lynda
机构：
[1] El Camino Hosp, Mountain View, CA USA
[2] Apr Hlth LLC, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101
引用
收藏
页数：1
相关论文
共 50 条
  • [21] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [22] Immune signatures of treatment response and immune-related adverse events in melanoma patients under checkpoint inhibitor therapy
    Reschke, R.
    Gussek, P.
    Boldt, A.
    Sack, U.
    Koehl, U.
    Lordick, F.
    Kreuz, M.
    Reiche, K.
    Simon, J. C.
    Ziemer, M.
    Kunz, M.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E57 - E57
  • [23] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
    Schneider, Bryan J.
    Naidoo, Jarushka
    Santomasso, Bianca D.
    Lacchetti, Christina
    Adkins, Sherry
    Anadkat, Milan
    Atkins, Michael B.
    Brassil, Kelly J.
    Caterino, Jeffrey M.
    Chau, Ian
    Davies, Marianne J.
    Ernstoff, Marc S.
    Fecher, Leslie
    Ghosh, Monalisa
    Jaiyesimi, Ishmael
    Mammen, Jennifer S.
    Naing, Aung
    Nastoupil, Loretta J.
    Phillips, Tanyanika
    Porter, Laura D.
    Reichner, Cristina A.
    Seigel, Carole
    Song, Jung-Min
    Spira, Alexander
    Suarez-Almazor, Maria
    Swami, Umang
    Thompson, John A.
    Vikas, Praveen
    Wang, Yinghong
    Weber, Jeffrey S.
    Funchain, Pauline
    Bollin, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4073 - +
  • [24] Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
    Duraisamy, Prasanna
    Panicker, Vinitha Varghese
    Jose, Wesley Mannirathil
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [25] Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Inoue, Yusuke
    Inui, Naoki
    INTERNAL MEDICINE, 2024,
  • [26] Longitudinal immune and genomic monitoring reveals signatures of response and Immune-related adverse events in cancer patients receiving checkpoint inhibitor therapy
    Khan, Shaheen
    Gerber, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [27] Factors Associated with Immune-Related Adverse Events in Immune Checkpoint Inhibitor Users
    Jung, Sun-Young
    Nam, Dal Ri
    Jung, Yu-Seon
    Lee, Jongmin
    Kim, Eunji
    DRUG SAFETY, 2024, 47 (12) : 1426 - 1426
  • [28] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Zheng, Shu-Yue
    Duan, Hua
    Cui, Hui-Juan
    JAMA ONCOLOGY, 2020, 6 (11) : 1813 - 1813
  • [29] Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
    Muir, Christopher A.
    Clifton-Bligh, Roderick J.
    Long, Georgina, V
    Scolyer, Richard A.
    Lo, Serigne N.
    Carlino, Matteo S.
    Tsang, Venessa H. M.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3704 - E3713
  • [30] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
12345